Breast CancerKelly K. Hunt, Geoffrey L. Robb, Eric A. Strom, Naoto T. Ueno Springer Science & Business Media, 5 jun 2013 - 520 páginas I am honored to write the Foreword for this first volume of the M. D. Anderson Cancer Care series, because I believe the book represents a milestone not only for M. D. Anderson but also for cancer specialists everywhere. All of us, whether we work in academic medical institu tions, medical school hospitals, community hospitals, oncology clinics, or solo practice, have seen remarkable changes in our practice over the recent decades. We know that breast cancer patients live longer, feel better, and look better than ever before, and they face this dreaded disease with more optimism than ever before. Each of us deserves to be proud of this progress. Though I am now primarily a laboratory scientist and admin istrator, I am proud of my own work on factors that control the growth of tumor cells, most prominently through regulation of EGF receptors and HER-2/neu, and the promise that work holds for women who have breast cancer. The authors represented in this volume have made important contri butions to breast cancer care. Likewise, every reader of this book has and will continue to make critical contributions to the health of women with breast cancer. I would like to express the hope here that each of us takes the opportunity to step outside our subspecialties-surgeon, internist, radiation oncologist, pathologist, radiologist, laboratory scientist-and learn how we can better integrate our work with that of other specialists. |
Índice
Chapter 2 | 20 |
Chapter 3 | 55 |
Chapter 4 | 93 |
Chapter 5 | 128 |
Chapter 6 | 157 |
Chapter 7 | 187 |
Chapter 8 | 223 |
Chapter 9 | 255 |
Chapter 11 | 309 |
Chapter 12 | 342 |
Chapter 13 | 366 |
Chapter 14 | 382 |
Chapter 15 | 406 |
Chapter 16 | 430 |
Chapter 17 | 452 |
Chapter 18 | 467 |
Otras ediciones - Ver todo
Breast Cancer Kelly K. Hunt,Geoffrey L. Robb,Eric A. Strom,Naoto T. Ueno Vista previa restringida - 2007 |
Breast Cancer Kelly K. Hunt,Geoffrey L. Robb,Eric A. Strom No hay ninguna vista previa disponible - 2014 |
Términos y frases comunes
abnormalities advanced breast cancer aromatase inhibitors assessment associated axillary lymph node benign bilateral bone BRCA1 BRCA2 breast cancer patients breast cancer risk breast conservation therapy breast lesions breast reconstruction calcifications cells chest wall Clin Oncol clinical trials core needle biopsy cyclophosphamide DCIS detected diagnosis disease docetaxel dose doxorubicin ductal carcinoma endometrial estrogen evaluation excision excisional biopsy factors follow-up Gail model gene HDCT history of breast imaging implant increased risk inhibitors irradiation locally advanced breast lymphedema M. D. Anderson malignant mammogram mammography markers mass metastatic metastatic breast cancer mg/m² mutations needle localization Oncology oophorectomy ovarian cancer paclitaxel patients with breast patients with metastatic performed postmenopausal postoperative primary breast cancer prognostic prophylactic mastectomy radiation therapy radiograph raloxifene receptor regimens SDCT segmental mastectomy sentinel lymph node sexual skin sonography specimen stage surgery surgical symptoms tamoxifen techniques tissue TRAM flap trastuzumab treatment tumor ultrasound-guided vaginal women